MUNTER; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for MUNTER; Klaus.The latest application filed is for "substituted imidazopyridine amides and use thereof".

Company Profile

0.22.19

MUNTER; Klaus - Wulfrath DE
Munter; Klaus - Mulfrath N/A DE
Munter; Klaus - Wlfrath DE
Munter; Klaus - Leverkusen DE
Munter; Klaus - Wilfrath DE
Munter; Klaus - Mannheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Imidazopyridine Amides And Use Thereof App 20200339567 - MEIBOM; Daniel ; et al.	2020-10-29
7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof Grant 10,519,154 - Teller , et al. Dec	2019-12-31
Positive Allosteric Modulators Of Muscarinic M2 Receptor App 20190367516 - TELLER; Henrik ; et al.	2019-12-05
Positive allosteric modulators of muscarinic M2 receptor Grant 10,435,403 - Teller , et al. O	2019-10-08
7-substituted 1-pyridyl-naphthyridine-3-carboxylic Acid Amides And Use Thereof App 20190241562 - TELLER; Henrik ; et al.	2019-08-08
Positive Allosteric Modulators Of Muscarinic M2 Receptor App 20180297994 - TELLER; Henrik ; et al.	2018-10-18
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use Grant 9,051,316 - Barfacker , et al. June 9, 2	2015-06-09
Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof Grant 8,987,256 - Hahn , et al. March 24, 2	2015-03-24
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine Amides And Their Use App 20140100243 - BARFACKER; Lars ; et al.	2014-04-10
Substituted oxazolidinones and their use Grant 8,487,111 - Allerheiligen , et al. July 16, 2	2013-07-16
Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof Grant 8,436,180 - Barfacker , et al. May 7, 2	2013-05-07
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof Grant 8,404,709 - Figueroa Perez , et al. March 26, 2	2013-03-26
Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same Grant 8,399,471 - Figueroa Perez , et al. March 19, 2	2013-03-19
Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors Grant 8,329,716 - Schirok , et al. December 11, 2	2012-12-11
Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders Grant 7,998,988 - Bartel , et al. August 16, 2	2011-08-16
Oxo-heterocyclic Substituted Carboxylic Acid Derivatives And The Use Thereof App 20110034450 - Hahn; Michael ; et al.	2011-02-10
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines And Use Thereof App 20100305052 - Figueroa Perez; Santiago ; et al.	2010-12-02
Substituted Oxazolidinones And Their Use App 20100261759 - Allerheiligen; Swen ; et al.	2010-10-14
Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors Grant 7,737,153 - Feurer , et al. June 15, 2	2010-06-15
Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides And Use Thereof App 20100136142 - Barfacker; Lars ; et al.	2010-06-03
Substituted phenylamino-pyrimidines Grant 7,723,347 - Schirok , et al. May 25, 2	2010-05-25
5-aryl-substituted Dihydropyridopyrimidines And Dihydropyridazines And Use Thereof As Mineral Corticoid Antagonists App 20100035902 - Figueroa Perez; Santiago ; et al.	2010-02-11
Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases App 20090227640 - Bartel; Stephan ; et al.	2009-09-10
Isophthalic acid derivatives Grant 7,498,460 - Harter , et al. March 3, 2	2009-03-03
Substituted Phenylamino-Pyrimidines App 20080269268 - Schirok; Hartmut ; et al.	2008-10-30
Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors App 20080139595 - Schirok; Hartmut ; et al.	2008-06-12
Carbamate-substituted pyrazolopyridines Grant 7,173,037 - Alonso-Alija , et al. February 6, 2	2007-02-06
Derivatives of 2-(1-benzyl-1H-pyrazolo(3,4-B)pyridine-3-yl)-5(-4-pyridinyl)l-4-pyrimidin- amines and the use thereof as quanylate cyclase stimulators Grant 7,135,474 - Weigand , et al. November 14, 2	2006-11-14
Quinoxalinones and their use especially in the treatment of cardiovascular diseases App 20060247244 - Erguden; Jens-Kerim ; et al.	2006-11-02
Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors App 20060241127 - Feurer; Achim ; et al.	2006-10-26
Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension App 20060183665 - Ellinghaus; Peter ; et al.	2006-08-17
Isophtalic acid derivatives App 20060154912 - Harter; Michael ; et al.	2006-07-13
Carbamate-substituted pyrazolopyridines App 20060052397 - Alonso-Alija; Cristina ; et al.	2006-03-09
Derivatives of 2-(1-benzyl-1h-pyrazolo(3,4-b)pyridine-3-yl)- 5(-4-pyridiny)l-4- pyrimidinamines and the use thereof as quanylate cyclase stimulators App 20050222170 - Weigand, Stefan ; et al.	2005-10-06
Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparation Grant 6,329,384 - Munter , et al. December 11, 2	2001-12-11
Method for combating obesity Grant 6,197,780 - Munter , et al. March 6, 2	2001-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.